Abstract

BackgroundIn the past decade, miR‐100, miR‐146a, and miR‐210 were reported to be dysregulated in childhood acute lymphoblastic leukemia (ALL). However, effects of genetic variants in these three microRNAs have not been investigated in Chinese population.MethodsIn this study, we conducted a case‐control study to evaluate the relationship between genetic variants in miR‐100, miR‐146a, and miR‐210 and the risk of childhood ALL in Chinese population. Subsequently, plasma expression level of miR‐100 was also detected.ResultWe found that subjects carrying mutant homozygous TT genotype of miR‐100 rs543412 had a statistically significantly decreased risk of childhood ALL (adjusted odds ratio [OR] = 0.73, 95% confidence interval [CI] = 0.55‐0.97, P = 0.029). This protective effect was also observed among subjects whose parents were ever drinkers (adjusted OR = 0.53, 95% CI = 0.29‐0.94), or whose living house were ever painted (adjusted OR = 0.57, 95% CI = 0.34‐0.94). Besides, rs543412 variant homozygous TT had a significantly protective role in patients with childhood B‐ALL. Finally, we found that expression level of miR‐100 in plasma of childhood ALL cases was significantly higher than that of noncancer controls.ConclusionOur study suggested that there was significant association between the polymorphisms in miR‐100 (rs543412) and decreased susceptibility to childhood ALL.

Highlights

  • In the past decade, miR‐100, miR‐146a, and miR‐210 were reported to be dysregulated in childhood acute lymphoblastic leukemia (ALL)

  • We searched for genetic variants located in these three miRNAs, and investigated whether they were associated with susceptibility of childhood ALL in Chinese population by a case‐control study

  • Genetic variants located in or near miRNA genes were striking for their function of influencing miRNA binding capacity or expression level.[24,25]

Read more

Summary

Funding information

This study was supported by the National Natural Science Foundation of China (81602913, 81670155), the Natural Science Foundation of Jiangsu Province (BK20150085), Nanjing Medical Science and Technology Development Project (YKK15140), Nanjing Medical Science and Technology Development Foundation (QRX17164), Nanjing Science and Technology Development Foundation (201503043).

| BACKGROUND
| MATERIALS AND METHODS
| RESULTS
Findings
| DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call